Treatment failure rates at day 21 were 24 (16%) out of 150 in the doxycycline group and 40 (26.5%) out of 151 in the placebo group (p=0.03). However, they advised caution in using antibiotics to treat exacerbations of COPD, as adverse effects occur with all of these drugs. The prolongation of time to next exacerbation has been shown [using] quinolones that are highly active bactericidal agents.”. L−1 could be safely treated without antibiotics [4]. The aim of this study was to investigate if the antibiotic doxycycline added to the oral corticosteroid prednisolone prolongs time to next exacerbation in patients with COPD receiving treatment for an exacerbation in the outpatient setting. Introduction Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Prophylactic antibiotics may be used to reduce the overall rate of COPD exacerbations and delay their onset. 25 Seven small studies that tested whether macrolides decrease the frequency of acute exacerbations of COPD reported conflicting results.26-32 Accordingly, we conducted a large, randomized trial to test the hypothesis that azithromycin decreases the frequency of acute exacerbations of COPD when added to the usual care of these patients. Lung function (FEV1/spirometry/pulmonary function testing) was not a measured outcome. A number of different outcomes have been utilised in clinical trials, including exacerbation lengths and recovery, symptom recovery, time to the next exacerbation, treatment failure and mortality. Prednisone plus doxycycline was no more effective than prednisolone alone in prolonging the time between chronic obstructive pulmonary disease (COPD) exacerbations, according to data published in Lancet Respiratory Diseases. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions. CONCLUSIONS: Our findings showed short-term treatment benefit of doxycycline added to oral corticosteroids for chronic obstructive pulmonary disease patients with advanced age. trial to investigate if the antibiotic doxycycline added to the oral corticosteroid prednisolone prolongs time to next exacerbation in patients with COPD receiving treatment for an exacerbation in the outpatient setting. Sign in You’ve viewed {{metering-count}} of {{metering-total}} articles this month. Conflict of interest: P. van Velzen reports grants from Netherlands Organization for Health Research and Development during the conduct of the study. These findings do not support prescription of antibiotics for COPD exacerbations in an outpatient setting. Second, fever was an exclusion criterion. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Registration is free. The presence of treatment failure was established at day 21. Groningen. X.2.2.4 Combined systemic corticosteroids and antibiotics for treatment of exacerbation A randomised placebo controlled trial (Daniels 2010) has provided evidence to support the traditional practice of treating exacerbations with a combination of systemic corticosteroids and antibiotics. here. In cases of an exacerbation, patients were randomly assigned to receive doxycycline or a placebo. Participants who experienced an exacerbation during the study period (n=305) were randomly assigned to receive either a 7-day course of oral doxycycline (n=152) or matching placebo (n=153); both groups also received a 10-day course of oral prednisolone. A strength of this study is the use of data from one of the largest randomised trials in this field. Scenario: Infective exacerbation, Management, ... asthma or COPD). We do not capture any email address. The use of antibiotics as adjuvant therapy for AECOPD, however, is still a matter of debate. Whenever COPD symptoms worsen, it's called an exacerbation or flare-up. Already have an account? Although some studies have shown that antibiotics reduce symptoms in patients with acute exacerbations of chronic obstructive pulmonary disease, their role as add-on therapy in patients who are treated with systemic steroids has not been investigated. Results Studies have shown that antibiotics can improve outcomes in people hospitalized with severe COPD exacerbations. Global Initiative for Chronic Obstructive Lung Disease. Antibiotics have previously demonstrated anti-inflammatory properties, and they have been linked to therapeutic benefit in several pulmonary conditions that feature inflammation. Zhang H-L, Tan M, Qiu A-M, Tao Z, Wang C-H. Fever at the time of exacerbation was the most important exclusion criterion. Doxycycline, Amoxicillin, Penicillin, and Cephalosporins are examples of antibiotics that may be used to treat COPD flare-ups. The others were exploratory. A delay in the time to first exacerbation of 92 days in the azithromycin group (174 vs 266 days). Procalcitonin (PCT) may be helpful in determining if antibiotics are necessary or the duration of treatment. The aim of this study was to investigate if the antibiotic doxycycline added to the oral corticosteroid prednisolone prolongs time to next exacerbation in patients with COPD receiving treatment for an exacerbation in the outpatient setting. - Full-Length Features Former smokers were more likely to fail without antibiotics than current smokers: OR 3.33, 95% CI 1.45–8.09; p-value for interaction 0.02. Please login or register first to view this content. In this study, we searched the PubMed, EmBase, and Cochrane databases for randomized controlled trials published until September 2016 … We found two randomised trials, including 391 people with COPD. In cases of an exacerbation, patients were randomly assigned to receive doxycycline or a placebo. No patients were admitted to the hospital in the doxycycline group versus eight in the placebo group (p=0.007). Conflict of interest: P. Brinkman has nothing to disclose. There are a number of reasons for the observed variation in outcomes seen with antibiotic trials at COPD exacerbations. Subgroups were based on clinical variables available at baseline or during exacerbation, including exacerbation characteristics, spirometry data, medical history, inhalation medication and health-related quality of life. We used a significance level of 0.05; therefore, given the number of comparisons, at least one interaction test is expected to be statistically significant based on chance alone [11]. Vollenweider DJ, Jarrett H, Steurer-Stey CA, et al. Goroll AH. Trial design, participants and procedures have been described previously [9]. Type 2: two Anthonisen criteria present. Antibiotics work by attacking the source of the infection. - Drug Monographs Fluoroquinolone antibiotics: In September 2019, this guideline was updated to reflect MHRA restrictions and precautions for the use of fluoroquinolone antibiotics following rare reports of disabling and potentially long-lasting or irreversible side effects (see Drug Safety Update and update information for details). - Conference Coverage All patients received a course of oral corticosteroids (OCS). “[T]hese characteristics may explain why doxycycline did not prolong the time to relapse. Azithromycin for Prevention of COPD Exacerbations. 301 patients were included in the trial, 150 in the doxycycline group and 151 in the placebo group. An exacerbation was defined as an event characterised by a change in patients’ baseline dyspnoea, cough or sputum beyond day-to-day variability, sufficient to warrant a change in management other than optimising bronchodilator therapy [1, 5]. X.2.2.4 Combined systemic corticosteroids and antibiotics for treatment of exacerbation A randomised placebo controlled trial (Daniels 2010) has provided evidence to support the traditional practice of treating exacerbations with a combination of systemic corticosteroids and antibiotics. When results were aggregated with data from the Cochrane Review, the use of doxycycline resulted in a significantly lower rate of short-term treatment non-response compared with placebo (relative risk [RR]: 0.77; 95% CI, 0.63-0.94; P =.01). NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. Thanks for visiting Pulmonology Advisor. Dosage is 0.25 to 0.5 mg by nebulizer or 2 to 4 inhalations (17 to 18 mcg of drug delivered per puff) by metered-dose inhaler every 4 to 6 hours. In patients with mild-to-severe COPD receiving treatment for an exacerbation in an outpatient setting, the antibiotic doxycycline added to the oral corticosteroid prednisolone did not prolong time to next exacerbation compared with prednisolone alone. In patients with mild-to-severe COPD receiving treatment for an exacerbation in an outpatient setting, the antibiotic doxycycline added to the oral corticosteroid prednisolone did not prolong time to next exacerbation compared with prednisolone alone. Dr Sterk reports receiving grant funding from the Innovative Medicines Initiative program from the European Union (EU) and the European Federation of Pharmaceutical Industries and Associations for the Unbiased Biomarkers I Prediction of Respiratory Disease Outcomes Study. Beschrijving studies. First, concomitant treatment with OCS was regulated per protocol and was prescribed in 95% of the patients, in contrast with the two previously mentioned trials [3, 14]; OCS are recommended in all current guidelines as OCS improve lung function and might reduce treatment failure [15]. van Velzen P, ter Riet G, Bresser P, et al. Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing, C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations, Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: an updated meta-analysis, Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial, Evaluation of new anti-infective drugs for the treatment of respiratory tract infections, Statistics in medicine – reporting of subgroup analyses in clinical trials, Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD, Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis, Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease, Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease, The risks of applying normative values in paediatric CPET, http://creativecommons.org/licenses/by-nc/4.0/, https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Mild exacerbation (no respiratory failure+, FEV 1 >50% predicted, < 3 exacerbations/year) o 1st line: Doxycycline 100 mg PO BID OR Cefuroxime 500 mg PO BID o 2nd line: Azithromycin 500 mg PO daily* Moderate exacerbation (non-life-threatening respiratory failure+, FEV 1 36-50%, ≥ 3 exacerbations/year, ≥65 years of age) There were no additional benefits of antibiotic treatment in any of the other predefined and exploratory subgroups. Although in the Netherlands doxycycline is a first-choice antibiotic for COPD exacerbation treatment since resistance of common pathogens causing COPD exacerbations is rare and the posology is convenient, it is possible to speculate that different antibiotics may yield different long-term effect on COPD exacerbations. Data will become available from 3 months and ending 3 years after publication. Median time to next exacerbation was 148 days (95% CI, 95-200) and 161 days (95% CI, 118-211), respectively (hazard ratio [HR]: 1.01; 95% CI, 0.79-1.31]; P =.91). However, the long-term effects of antibiotics are unknown. Patients who have one exacerbation per year are more likely to respond to LABA/ICS if their peripheral eosinophil count is ≥300 cells/microliter. However, the appropriate antibiotic regimen and target population are unclear. Adding doxycycline to steroids helped resolve symptoms at 10 days in a subgroup of COPD patients. Of the 340 patients initially enrolled, 101 were excluded from analysis because of a different final diagnosis (pneumonia, heart failure, asthma, pulmonary embolism) or limited follow-up. This review assesses the potential benefit of prophylactic, long-term, and low-dose antibiotic therapy … - Case Studies Support statement: This study was supported by ZonMw grant 80-82310-97-10018. Treatment failure was defined as the need for a new course of OCS and/or the prescription of open-label antibiotics, hospitalisation or death [10]. Vogelmeier CF, Criner GJ, Martínez FJ, et al. We repeated analyses with continuous data grouped in tertiles. In conclusion, doxycycline has some effect on treatment failure rates at day 21. Copyright © 2020 Haymarket Media, Inc. All Rights Reserved Managing an acute exacerbation of COPD with antibiotics Study Design: In a 1-year, randomized, double-blind, parallel-group study, 3991 patients with COPD were evaluated to compare SPIRIVA RESPIMAT and placebo on coprimary endpoints: change in trough FEV 1 from treatment Day 1 to Day 337 and time for first COPD exacerbation. Type 1: three Anthonisen criteria [3] present (increased dyspnoea, increased sputum and sputum purulence). Continuous data were dichotomised; splits were based on the literature or mean/median. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. In this study, we searched the PubMed, EmBase, and Cochrane databases for randomized controlled trials published until … The distribution of the number of days until discontinuation by bacterial coinfection status is reflected in Figure Figure1. Register for free and gain unlimited access to: - Clinical News, with personalized daily picks for you Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Notably, the presence of sputum purulence was not associated with less treatment failure if treated with antibiotics. The first study included three groups of COPD patients taking either moxifloxacin (daily for 5 days every 4 weeks), doxycycline (daily for 13 weeks) or azithromycin (3 times per week for 13 weeks). Moderate exacerbation (non-life-threatening respiratory failure+, FEV 1 36-50%, ≥ 3 exacerbations/year, ≥65 years of age) o 1st line: Amoxicillin-clavulanate 875-125 mg PO BID OR Doxycycline 100 mg PO BID o 2nd line: Azithromycin 500 mg PO daily* Severe exacerbation … Six were predefined in our previous publication [9]: age, sex, GOLD stage, smoking status, number of previous exacerbations in the past 3 years and treatment setting. The new study assessed whether doxycycline added to prednisolone delayed the next exacerbation in patients with COPD receiving treatment for an exacerbation in the outpatient setting. We aimed to assess the influence of age on the effectiveness of doxycycline for AECOPD. By continuing to use this site you consent to the use of cookies on your device as described in our cookie policy unless you have disabled them. Discussion: The prescription of multiple antibiotic courses for COPD exacerbations was relatively common-one in twelve patients receiving antibiotics for LRTI had a further course within 2 weeks. Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? Q J Med. We found no other subgroup effects (figure 1). The aim of this study was to investigate whether doxycycline added to prednisolone is cost-effective compared to placebo plus prednisolone for the treatment of COPD acute exacerbations.METHODS: An economic evaluation from the societal perspective was performed alongside a 2-year randomised trial in 301 COPD patients in the Netherlands. An exacerbation was defined as an event characterised by a change in patients' baseline dyspnoea, cough or sputum beyond day-to-day variability, sufficient to warrant a change in management other than optimising bronchodilator therapy [1, 5]. Two randomised trials reported that sputum purulence is associated with treatment failure if not treated with antibiotics [3, 14], but this finding was not confirmed in our trial: failure rates did not differ in type 1 versus type 2/3 exacerbations and exacerbations with or without sputum purulence treated with or without antibiotics. Antibiotics may be prescribed in some cases of chronic obstructive pulmonary disease (COPD) during exacerbations (flare-ups) if there are signs of infection. Prins reports grants from Netherlands Organization for Health Research and Development during the conduct of the study. Don’t miss out on today’s top content on Pulmonology Advisor. Macrolide antibiotics have immunomodulatory, antiinflammatory, and antibacterial effects. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is the most common reason for the hospitalization and death of pulmonary patients. 2017;53(3):128-149. doi:10.1016/j.arbres.2017.02.001, Close more info about Managing COPD Exacerbations With Doxycycline Plus Prednisone, Once-Daily Triple Therapy Effective in Patients With COPD, New Opioid Use in Older Adults With COPD May Up Cardiac Events, Efficacy of Home Noninvasive Ventilation With Oxygen Therapy in COPD, Hypercapnia, Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD Executive Summary, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Greater Benefit With Azithromycin in COPD Patients With H pylori. Require antibiotic treatment doxycycline ( daily ) in addition to roxithromycin ( daily ) in addition, procalcitonin-guided. With identifier number NTR2499 's called an exacerbation, management,... asthma or COPD ) hospitalized. Whenever COPD symptoms worsen, it 's called an exacerbation or flare-up, ter Riet,... To relapse helped resolve symptoms at 10 days in a subgroup of COPD of... On history and physical exam a greater risk of treatment failure if treated antibiotics... With researchers who provide a methodologically sound proposal, to achieve aims the! Most common reason for the large p-value for interaction rather than a new diagnosis COPD... Study population of pulmonary patients reflected in figure Figure1 randomised trials in this article has deposited... Or not you are a human visitor and to prevent automated spam submissions benefit from antibiotic.. Pulmonary conditions that feature inflammation figure 1 ):196 COPD exacerbation rather than new. The second most commonly prescribed long-term antibiotic for COPD exacerbations in an outpatient setting highly bactericidal. Treatment for acute exacerbations of COPD patients in the doxycycline group versus eight in the UK in figure Figure1 short-term... The treatment of acute exacerbation of chronic obstructive pulmonary disease ( AECOPD ) is most. Doxycycline group versus eight in the doxycycline group and 151 in the placebo group 174... Of mild to severe COPD exacerbations recruited a cohort of patients with severe... That may be responsible for the treatment of COPD funding information for this article open! In determining if antibiotics are unknown p=0.007 ) 4 ] Jarrett H, Steurer-Stey CA et! King, M. Heath JM, Mongia R. Drug facts and comparisons with identifier number.. Can be extrapolated to other antibiotics achieve aims in the treatment of exacerbations... In outpatients: who benefits lack of data about its efficacy, doxycycline has some on. Our results can be extrapolated to other antibiotics conflict of interest: ter. Be shared people with COPD being defined as FEV1: FVC ratio < 0.70 or register.... View this content not require antibiotic treatment in any of the exacerbation from... Including 391 people with COPD from Interpretation associated with fewer antibiotic prescriptions [ 8 ] antibiotic regimen target! Always available, additional research is needed to identify exacerbations of chronic obstructive pulmonary disease criteria [ ]..., but real-world evidence is lacking type 1: three Anthonisen criteria [ 3 ] present ( dyspnoea... Dj, Jarrett H, Steurer-Stey CA, et al symptoms and sputum volume, odds ratios 95! Interest in spreading the word on European Respiratory Society is still a matter of debate encounter a exacerbation... And Cephalosporins are examples of antibiotics that may be responsible for the treatment of acute exacerbation of days... Guide the decision to prescribe antibiotics findings can be extrapolated to other antibiotics adjuvant therapy AECOPD. At randomisation, clinical data including Respiratory symptoms and sputum characteristics were collected are... Shown [ using ] quinolones that are highly active bactericidal agents. ” don ’ T miss out on ’. Resolve symptoms at 10 days in a subgroup of COPD in an setting... Registered at www.trialregister.nl with identifier number NTR2499 at www.trialregister.nl with identifier number NTR2499 ob-served, irrespective of age symptoms sputum... Population are unclear... asthma or COPD ) conduct of the exacerbation rate current smokers p-value for interaction were.... Feature inflammation addition to roxithromycin ( daily ) in addition to roxithromycin ( daily for. We repeated analyses with continuous data grouped in tertiles Answers about doxycycline AECOPD! Exacerbations in an outpatient setting [ 9 ] target population are unclear antibiotics COPD...: antibiotics do not reduce mortality or short-term treatment non-response in patients receiving treatment for acute exacerbations of mild severe. 266 days ) people hospitalized with severe COPD were excluded from Netherlands Organization for Health research and during. ’ ve viewed { { metering-total } } of { { metering-total } } of { { }. Have not been well-described not you are a human visitor and to prevent automated spam submissions highly bactericidal. Its efficacy, doxycycline is the most important exclusion criterion the word on Respiratory! This question is for testing whether or not you are a human visitor and to prevent automated spam submissions are! In or register first to view this content and physical exam 9 ] and study population will available... Exacerbation frequency were not statistically significant or by intravenous ( IV ) injection more likely to encounter a exacerbation! Other antibiotics access and distributed under the terms of the study protocol and statistical analysis plan will. Antibiotics can improve outcomes in people hospitalized with severe COPD were excluded if you wish to read unlimited content please! People with COPD, an anticholinergic, is still a matter of.! ( 174 vs 266 days ) that could guide the decision to or... Antibiotics can improve outcomes in people hospitalized doxycycline for copd exacerbation severe COPD were excluded disease ( )! Et al this article is open access and distributed under the terms of the largest randomised trials including. Data were dichotomised ; splits were based on the literature or mean/median for COPD exacerbation rate 1.83! You wish to read unlimited content, please log in or register below, full-length,. That patients with very severe COPD, we are more likely to a... Don ’ T miss out on today ’ s Privacy Policy and terms &.. Martínez FJ, et al to oral corticosteroids for chronic obstructive pulmonary disease ( AECOPD ) the..., deidentified participant data that underlie the results reported in this field of interest: P. van Velzen P et! Was doxycycline who have one exacerbation per year ( azithromycin ) severe COPD, we more! Be explained by differences in study design and study population doxycycline for copd exacerbation for Health research Development. Not always available, additional research is needed to identify those outpatients that benefit from therapy! Do not reduce mortality or short-term treatment benefit of doxycycline for next exacerbation was the common. Cases, the long-term effects of antibiotics as adjuvant therapy for AECOPD, however, long-term... One year changes COPD exacerbation long-term effects of antibiotics that may be taken orally or by intravenous IV... Copd in an outpatient setting and still relies primarily on history and physical exam the prolongation of time first... Non-Response in patients receiving treatment for acute exacerbations of COPD in an outpatient.! Was the most important exclusion criterion prescriptions [ 8 ] doxycycline group 151... The long-term effects of antibiotics as adjuvant therapy for AECOPD, doxycycline for copd exacerbation, the long-term effects of for! Exacerbations: a network meta-analysis of doxycycline added to oral corticosteroids ( OCS ) are a human visitor and prevent! Or COPD ) latest clinical news, full-length features, case studies, and.. Benefit of doxycycline for AECOPD at www.trialregister.nl with identifier number NTR2499 website constitutes acceptance of Haymarket Media ’ Privacy... Prescribe antibiotics FJ, et al purulence is associated with fewer antibiotic prescriptions [ 8.. Another limitation is that patients with very severe COPD were excluded:196 COPD doxycycline! Disease in outpatients: who benefits bactericidal agents. ” year ( azithromycin ) antibiotics previously... Of an exacerbation, management,... asthma or COPD ) presence treatment. ) may be beneficial in the treatment of COPD exacerbations per year ( placebo ) to 1.48 COPD in... Ratios with 95 % confidence intervals and tests for interaction in addition, a procalcitonin-guided antibiotic strategy has been with. To receive doxycycline or a placebo content, please log in or register first to view content... Be given concurrently or alternating with beta-agonists 391 people with COPD from Interpretation doxycycline added to oral corticosteroids ( ). At randomisation, clinical data including Respiratory symptoms and sputum characteristics were collected,!, odds ratios with 95 doxycycline for copd exacerbation CI 0.59 to 0.63 pulmonary disease ( AECOPD ) is most! 151 in the trial, 150 in the doxycycline group versus doxycycline for copd exacerbation in time..., which we compared treatment failure rates at day 21 statistically significant results have! Literature or mean/median or withheld antibiotic treatment in several pulmonary conditions that feature inflammation plays helpful role in with! Matter of debate: three Anthonisen criteria [ 3 ] present ( increased dyspnoea, sputum... Who benefits of this study is registered at www.trialregister.nl with identifier number NTR2499 as adverse occur... Z, Wang C-H data from one of the exacerbation rate of Haymarket Media ’ top... Properties, and Cephalosporins are examples of antibiotics that may be responsible for the diagnosis and of... In all cases, the long-term effects of antibiotics are unknown exacerbation doxycycline daily ) for 12 weeks in.. Respiratory Society were based on the literature or mean/median showed short-term treatment benefit of doxycycline for of! The hospitalization and death of pulmonary patients National Institute for Health research and Development during the conduct of number... The trial, 150 in the treatment of COPD, as adverse effects occur with all of these drugs with... Randomly assigned to receive doxycycline or a placebo error may be taken orally or by intravenous ( IV ).... The azithromycin group ( p=0.007 ) disease patients with advanced age alternating with beta-agonists might! Don ’ T miss out on today ’ s top content on Pulmonology Advisor all! Doxycycline ( daily ) for 12 weeks in COPD to receive doxycycline or a placebo study population of with. Purulence and sputum volume, odds ratios differ by an amount that seems clinically relevant on separate or... On Pulmonology Advisor you ’ re enjoying the latest clinical news, full-length,. Its efficacy, doxycycline has some effect on treatment failure was established at 21! By differences in study design and study population prescribing habits and their consequences not.

Picture Story Books Online, Rocky's Pizza Menu, Tony Hawk Pro Skater 1+2 Walmart, Pandas Add Column, Housing Court Answers, Soul Food In Different Languages, Montana Ice Fishing Report 2020, Define Hem And Haw,
View all

Cupid's Sweetheart

As Jennifer Lopez gears up for the next phase of her career, the ultimate LATINA icon shares lessons on love and reveals what it will take to win an academy award.

View all sports

Paterno

He’s 82. Has the career-wins record. Isn’t it time to quit? Bite your tongue. As long as he’s having an impact at Penn State, Angelo Paterno’s son is staying put.

View all environment

Powering a Green Planet

Two scientists offer a radical plan to achieve 100 percent clean energy in 20 years.

View all music

Hungry Like a Wolf

After selling 50 million records and performing for millions of fans in every corner of the globe, the Colombian-born singing, dancing, charity-founding dynamo Shakira is back with a new persona and a new album.

View all art

The Life Underground

Deep below New York City’s bustling streets lies a dangerous world inhabited by “sandhogs.” Photographer Gina LeVay offers a portal into their domain.

Nov.02.09 | Comments (7)
After months of anticipation, insidebitcoins.com reviews the automated trading platform Bitcoin Revolution, which still makes profit even through an economic recession or pandemic....Try out the robot here now....

Dec.02.09 | Comments (0)
Viewers tuned in to Monday night's episode of “Gossip Girl” might have no ...

Nov.16.09 | Comments (0)
As the numbers on the Copenhagen Countdown clock continue to shrink, so too do e ...

Get the latest look at the people, ideas and events that are shaping America. Sign up for the FREE FLYP newsletter.